Event Details

Verastem Research and Development Day and discussion of acquisition of Clinical-Stage FAK Inhibitor from Pfizer

Jul 12, 2012 at 9:00 AM EDT

Webcast Presentation

Live Teleconference Information

Primary # -
866 700.7173
Secondary # -
617 213.8838
Passcode -
73322380
Event Details
Title
Verastem Research and Development Day and discussion of acquisition of Clinical-Stage FAK Inhibitor from Pfizer
Date / Time
Jul 12, 2012 at 9:00 AM EDT

E-mail Alerts

You may automatically receive Verastem Oncology financial information by e-mail. To choose your options for e-mail notification, please enter your e-mail address below and click Submit.

Investor Contact

getty
Julissa Viana

Investor Relations
investors@verastem.com

Ryan Porter

Argot Partners
+1 212-600-1902
ryan.porter@argotpartners.com

Investor Kit
img